Motor Function and Dopamine Release Measurements in Transgenic Huntington’s Disease Model Rats
dc.contributor.author | Oritz, Andrea N. | |
dc.contributor.author | Osterhaus, Gregory L. | |
dc.contributor.author | Lauderdale, Kelli | |
dc.contributor.author | Mahoney, Luke | |
dc.contributor.author | Fowler, Stephen C. | |
dc.contributor.author | von Hörsten, Stephan | |
dc.contributor.author | Riess, Olaf | |
dc.contributor.author | Johnson, Michael A. | |
dc.date.accessioned | 2017-02-20T21:52:03Z | |
dc.date.available | 2017-02-20T21:52:03Z | |
dc.date.issued | 2012-02-24 | |
dc.identifier.citation | Ortiz, Andrea N., Gregory L. Osterhaus, Kelli Lauderdale, Luke Mahoney, Stephen C. Fowler, Stephan Von Hörsten, Olaf Riess, and Michael A. Johnson. "Motor Function and Dopamine Release Measurements in Transgenic Huntington's Disease Model Rats." Brain Research 1450 (2012): 148-56. | en_US |
dc.identifier.uri | http://hdl.handle.net/1808/23203 | |
dc.description.abstract | Huntington’s disease (HD) is a fatal, genetic, neurodegenerative disorder characterized by deficits in motor and cognitive function. Here, we have quantitatively characterized motor deficiencies and dopamine release dynamics in transgenic HD model rats. Behavioral analyses were conducted using a newly-developed force-sensing runway and a previously-developed force-plate actometer. Gait disturbances were readily observed in transgenic HD rats at 12 to 15 months of age. Additionally, dopamine system challenge by ip injection of amphetamine also revealed that these rats were resistant to the expression of focused stereotypy compared to wild-type controls. Moreover, dopamine release, evoked by the application of single and multiple electrical stimulus pulses applied at different frequencies, and measured using fast-scan cyclic voltammetry at carbon-fiber microelectrodes, was diminished in transgenic HD rats compared to age-matched wild-type control rats. Collectively, these results underscore the potential contribution of dopamine release alterations to the expression of motor impairments in transgenic HD rats. | en_US |
dc.publisher | Elsevier | en_US |
dc.rights | This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License 3.0 (CC BY-NC-ND 3.0 US), which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. | en_US |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/ | |
dc.subject | Dopamine | en_US |
dc.subject | Huntington's disease | en_US |
dc.subject | Microelectrodes | en_US |
dc.subject | Voltammertry | en_US |
dc.subject | Behavior | en_US |
dc.subject | Transgenic | en_US |
dc.title | Motor Function and Dopamine Release Measurements in Transgenic Huntington’s Disease Model Rats | en_US |
dc.type | Article | en_US |
kusw.kuauthor | Fowler, Stephen C. | |
kusw.kudepartment | Pharmacology & Toxicology | en_US |
kusw.oanotes | Per SHERPA/RoMEO 2/20/2017: Author's Pre-print: green tick author can archive pre-print (ie pre-refereeing) Author's Post-print: green tick author can archive post-print (ie final draft post-refereeing) Publisher's Version/PDF: cross author cannot archive publisher's version/PDF General Conditions: Authors pre-print on any website, including arXiv and RePEC Author's post-print on author's personal website immediately Author's post-print on open access repository after an embargo period of between 12 months and 48 months Permitted deposit due to Funding Body, Institutional and Governmental policy or mandate, may be required to comply with embargo periods of 12 months to 48 months Author's post-print may be used to update arXiv and RepEC Publisher's version/PDF cannot be used Must link to publisher version with DOI Author's post-print must be released with a Creative Commons Attribution Non-Commercial No Derivatives License | en_US |
dc.identifier.doi | 10.1016/j.brainres.2012.02.042 | en_US |
kusw.oaversion | Scholarly/refereed, author accepted manuscript | en_US |
kusw.oapolicy | This item meets KU Open Access policy criteria. | en_US |
dc.rights.accessrights | openAccess |
Files in this item
This item appears in the following Collection(s)
-
Pharmacy Scholarly Works [286]
Except where otherwise noted, this item's license is described as: This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License 3.0 (CC BY-NC-ND 3.0 US), which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.